×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
TOPIC 2 SESSION 5 CONTINUED: Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies
Session Chair(s)
Gaby L. Danan, MD, PhD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert